nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0714	0.098	CbGbCtD
Ofloxacin—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0706	0.0969	CbGbCtD
Ofloxacin—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0616	0.0846	CbGbCtD
Ofloxacin—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0541	0.0743	CbGbCtD
Ofloxacin—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0541	0.0743	CbGbCtD
Ofloxacin—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0535	0.0734	CbGbCtD
Ofloxacin—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0456	0.0626	CbGbCtD
Ofloxacin—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0401	0.0551	CbGbCtD
Ofloxacin—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.04	0.055	CbGbCtD
Ofloxacin—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.04	0.055	CbGbCtD
Ofloxacin—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0297	0.0408	CbGbCtD
Ofloxacin—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0281	0.0386	CbGbCtD
Ofloxacin—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0232	0.0318	CbGbCtD
Ofloxacin—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0218	0.0299	CbGbCtD
Ofloxacin—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0218	0.0299	CbGbCtD
Ofloxacin—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0217	0.0298	CbGbCtD
Ofloxacin—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0197	0.027	CbGbCtD
Ofloxacin—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0165	0.0227	CbGbCtD
Ofloxacin—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0149	0.0205	CbGbCtD
Ofloxacin—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000865	0.0586	CbGeAlD
Ofloxacin—TOP2A—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.00083	0.271	CbGdCrCtD
Ofloxacin—TOP2A—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.00076	0.248	CbGdCrCtD
Ofloxacin—TOP2A—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.00076	0.248	CbGdCrCtD
Ofloxacin—TOP2A—blood—acquired immunodeficiency syndrome	0.00066	0.0448	CbGeAlD
Ofloxacin—TOP2A—bone marrow—acquired immunodeficiency syndrome	0.000639	0.0433	CbGeAlD
Ofloxacin—TOP2A—vagina—acquired immunodeficiency syndrome	0.000612	0.0415	CbGeAlD
Ofloxacin—TOP2A—lung—acquired immunodeficiency syndrome	0.000579	0.0392	CbGeAlD
Ofloxacin—Gatifloxacin—ALB—acquired immunodeficiency syndrome	0.000559	1	CrCbGaD
Ofloxacin—SLC22A4—digestive system—acquired immunodeficiency syndrome	0.000555	0.0376	CbGeAlD
Ofloxacin—SLC22A4—blood—acquired immunodeficiency syndrome	0.000529	0.0358	CbGeAlD
Ofloxacin—SLC22A5—retina—acquired immunodeficiency syndrome	0.000523	0.0354	CbGeAlD
Ofloxacin—SLC22A4—bone marrow—acquired immunodeficiency syndrome	0.000511	0.0347	CbGeAlD
Ofloxacin—SLC22A4—spinal cord—acquired immunodeficiency syndrome	0.000509	0.0345	CbGeAlD
Ofloxacin—SLC22A4—vagina—acquired immunodeficiency syndrome	0.00049	0.0332	CbGeAlD
Ofloxacin—SLC22A6—brain—acquired immunodeficiency syndrome	0.00048	0.0325	CbGeAlD
Ofloxacin—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000474	0.0321	CbGeAlD
Ofloxacin—SLC22A4—lung—acquired immunodeficiency syndrome	0.000463	0.0314	CbGeAlD
Ofloxacin—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000459	0.0311	CbGeAlD
Ofloxacin—ABCC2—blood—acquired immunodeficiency syndrome	0.000451	0.0306	CbGeAlD
Ofloxacin—ABCC1—blood—acquired immunodeficiency syndrome	0.000398	0.027	CbGeAlD
Ofloxacin—TOP2A—lymph node—acquired immunodeficiency syndrome	0.000396	0.0268	CbGeAlD
Ofloxacin—TOP2A—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000373	0.122	CbGdCrCtD
Ofloxacin—ABCC1—vagina—acquired immunodeficiency syndrome	0.000369	0.025	CbGeAlD
Ofloxacin—SLC22A5—digestive system—acquired immunodeficiency syndrome	0.000367	0.0249	CbGeAlD
Ofloxacin—SLC22A5—blood—acquired immunodeficiency syndrome	0.00035	0.0237	CbGeAlD
Ofloxacin—ABCC1—lung—acquired immunodeficiency syndrome	0.000349	0.0236	CbGeAlD
Ofloxacin—TOP2A—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.000343	0.112	CbGdCrCtD
Ofloxacin—SLC22A5—spinal cord—acquired immunodeficiency syndrome	0.000337	0.0228	CbGeAlD
Ofloxacin—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000333	0.0225	CbGeAlD
Ofloxacin—SLC22A4—brain—acquired immunodeficiency syndrome	0.000328	0.0222	CbGeAlD
Ofloxacin—SLC22A5—vagina—acquired immunodeficiency syndrome	0.000324	0.022	CbGeAlD
Ofloxacin—SLC22A4—lymph node—acquired immunodeficiency syndrome	0.000317	0.0215	CbGeAlD
Ofloxacin—CYP1A2—blood—acquired immunodeficiency syndrome	0.000317	0.0215	CbGeAlD
Ofloxacin—SLC22A5—lung—acquired immunodeficiency syndrome	0.000307	0.0208	CbGeAlD
Ofloxacin—CYP1A2—lung—acquired immunodeficiency syndrome	0.000278	0.0188	CbGeAlD
Ofloxacin—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000271	0.0183	CbGeAlD
Ofloxacin—ABCC1—brain—acquired immunodeficiency syndrome	0.000247	0.0167	CbGeAlD
Ofloxacin—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000238	0.0162	CbGeAlD
Ofloxacin—SLC22A5—brain—acquired immunodeficiency syndrome	0.000217	0.0147	CbGeAlD
Ofloxacin—SLC22A5—lymph node—acquired immunodeficiency syndrome	0.00021	0.0142	CbGeAlD
Ofloxacin—Anxiety—Ritonavir—acquired immunodeficiency syndrome	7.29e-05	0.000288	CcSEcCtD
Ofloxacin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	7.27e-05	0.000287	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	7.26e-05	0.000287	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	7.24e-05	0.000286	CcSEcCtD
Ofloxacin—Pruritus—Abacavir—acquired immunodeficiency syndrome	7.23e-05	0.000286	CcSEcCtD
Ofloxacin—Fatigue—Indinavir—acquired immunodeficiency syndrome	7.23e-05	0.000286	CcSEcCtD
Ofloxacin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	7.23e-05	0.000285	CcSEcCtD
Ofloxacin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	7.23e-05	0.000285	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	7.22e-05	0.000285	CcSEcCtD
Ofloxacin—Cough—Saquinavir—acquired immunodeficiency syndrome	7.21e-05	0.000285	CcSEcCtD
Ofloxacin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	7.21e-05	0.000285	CcSEcCtD
Ofloxacin—Constipation—Indinavir—acquired immunodeficiency syndrome	7.17e-05	0.000283	CcSEcCtD
Ofloxacin—Pain—Indinavir—acquired immunodeficiency syndrome	7.17e-05	0.000283	CcSEcCtD
Ofloxacin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	7.17e-05	0.000283	CcSEcCtD
Ofloxacin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	7.16e-05	0.000283	CcSEcCtD
Ofloxacin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	7.15e-05	0.000283	CcSEcCtD
Ofloxacin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	7.14e-05	0.000282	CcSEcCtD
Ofloxacin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	7.13e-05	0.000282	CcSEcCtD
Ofloxacin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	7.13e-05	0.000282	CcSEcCtD
Ofloxacin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	7.12e-05	0.000281	CcSEcCtD
Ofloxacin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	7.11e-05	0.000281	CcSEcCtD
Ofloxacin—Malaise—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.000281	CcSEcCtD
Ofloxacin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	7.1e-05	0.00028	CcSEcCtD
Ofloxacin—Nausea—Didanosine—acquired immunodeficiency syndrome	7.1e-05	0.00028	CcSEcCtD
Ofloxacin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	7.09e-05	0.00028	CcSEcCtD
Ofloxacin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	7.08e-05	0.00028	CcSEcCtD
Ofloxacin—Syncope—Lamivudine—acquired immunodeficiency syndrome	7.07e-05	0.000279	CcSEcCtD
Ofloxacin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	7.07e-05	0.000279	CcSEcCtD
Ofloxacin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	7.06e-05	0.000279	CcSEcCtD
Ofloxacin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	7.06e-05	0.000279	CcSEcCtD
Ofloxacin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	7.04e-05	0.000278	CcSEcCtD
Ofloxacin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	7.04e-05	0.000278	CcSEcCtD
Ofloxacin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	7.04e-05	0.000278	CcSEcCtD
Ofloxacin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	7.04e-05	0.000278	CcSEcCtD
Ofloxacin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	7.01e-05	0.000277	CcSEcCtD
Ofloxacin—Oedema—Ritonavir—acquired immunodeficiency syndrome	7.01e-05	0.000277	CcSEcCtD
Ofloxacin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	6.99e-05	0.000276	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	6.99e-05	0.000276	CcSEcCtD
Ofloxacin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	6.97e-05	0.000276	CcSEcCtD
Ofloxacin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	6.95e-05	0.000275	CcSEcCtD
Ofloxacin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	6.93e-05	0.000274	CcSEcCtD
Ofloxacin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	6.91e-05	0.000273	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	6.91e-05	0.000273	CcSEcCtD
Ofloxacin—Shock—Ritonavir—acquired immunodeficiency syndrome	6.9e-05	0.000272	CcSEcCtD
Ofloxacin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	6.89e-05	0.000272	CcSEcCtD
Ofloxacin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	6.88e-05	0.000272	CcSEcCtD
Ofloxacin—Cough—Lamivudine—acquired immunodeficiency syndrome	6.88e-05	0.000272	CcSEcCtD
Ofloxacin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	6.88e-05	0.000272	CcSEcCtD
Ofloxacin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	6.88e-05	0.000272	CcSEcCtD
Ofloxacin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	6.86e-05	0.000271	CcSEcCtD
Ofloxacin—Dizziness—Stavudine—acquired immunodeficiency syndrome	6.86e-05	0.000271	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	6.86e-05	0.000271	CcSEcCtD
Ofloxacin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	6.86e-05	0.000271	CcSEcCtD
Ofloxacin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	6.84e-05	0.00027	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	6.84e-05	0.00027	CcSEcCtD
Ofloxacin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	6.83e-05	0.00027	CcSEcCtD
Ofloxacin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	6.83e-05	0.00027	CcSEcCtD
Ofloxacin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	6.81e-05	0.000269	CcSEcCtD
Ofloxacin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	6.81e-05	0.000269	CcSEcCtD
Ofloxacin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	6.8e-05	0.000269	CcSEcCtD
Ofloxacin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	6.78e-05	0.000268	CcSEcCtD
Ofloxacin—Pain—Efavirenz—acquired immunodeficiency syndrome	6.78e-05	0.000268	CcSEcCtD
Ofloxacin—Constipation—Efavirenz—acquired immunodeficiency syndrome	6.78e-05	0.000268	CcSEcCtD
Ofloxacin—Rash—Nevirapine—acquired immunodeficiency syndrome	6.78e-05	0.000268	CcSEcCtD
Ofloxacin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	6.77e-05	0.000267	CcSEcCtD
Ofloxacin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	6.76e-05	0.000267	CcSEcCtD
Ofloxacin—Dizziness—Abacavir—acquired immunodeficiency syndrome	6.76e-05	0.000267	CcSEcCtD
Ofloxacin—Oedema—Saquinavir—acquired immunodeficiency syndrome	6.75e-05	0.000267	CcSEcCtD
Ofloxacin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	6.74e-05	0.000266	CcSEcCtD
Ofloxacin—Headache—Nevirapine—acquired immunodeficiency syndrome	6.73e-05	0.000266	CcSEcCtD
Ofloxacin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	6.71e-05	0.000265	CcSEcCtD
Ofloxacin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	6.71e-05	0.000265	CcSEcCtD
Ofloxacin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	6.71e-05	0.000265	CcSEcCtD
Ofloxacin—Infection—Saquinavir—acquired immunodeficiency syndrome	6.7e-05	0.000265	CcSEcCtD
Ofloxacin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	6.69e-05	0.000264	CcSEcCtD
Ofloxacin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	6.68e-05	0.000264	CcSEcCtD
Ofloxacin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	6.67e-05	0.000264	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	6.67e-05	0.000263	CcSEcCtD
Ofloxacin—Urticaria—Indinavir—acquired immunodeficiency syndrome	6.66e-05	0.000263	CcSEcCtD
Ofloxacin—Shock—Saquinavir—acquired immunodeficiency syndrome	6.64e-05	0.000262	CcSEcCtD
Ofloxacin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	6.63e-05	0.000262	CcSEcCtD
Ofloxacin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	6.63e-05	0.000262	CcSEcCtD
Ofloxacin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	6.63e-05	0.000262	CcSEcCtD
Ofloxacin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	6.62e-05	0.000261	CcSEcCtD
Ofloxacin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	6.62e-05	0.000261	CcSEcCtD
Ofloxacin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	6.61e-05	0.000261	CcSEcCtD
Ofloxacin—Vomiting—Stavudine—acquired immunodeficiency syndrome	6.6e-05	0.000261	CcSEcCtD
Ofloxacin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	6.59e-05	0.00026	CcSEcCtD
Ofloxacin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	6.57e-05	0.000259	CcSEcCtD
Ofloxacin—Rash—Nelfinavir—acquired immunodeficiency syndrome	6.56e-05	0.000259	CcSEcCtD
Ofloxacin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	6.56e-05	0.000259	CcSEcCtD
Ofloxacin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	6.55e-05	0.000259	CcSEcCtD
Ofloxacin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	6.55e-05	0.000259	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	6.55e-05	0.000259	CcSEcCtD
Ofloxacin—Rash—Stavudine—acquired immunodeficiency syndrome	6.54e-05	0.000258	CcSEcCtD
Ofloxacin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	6.54e-05	0.000258	CcSEcCtD
Ofloxacin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	6.54e-05	0.000258	CcSEcCtD
Ofloxacin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	6.53e-05	0.000258	CcSEcCtD
Ofloxacin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	6.52e-05	0.000258	CcSEcCtD
Ofloxacin—Headache—Nelfinavir—acquired immunodeficiency syndrome	6.52e-05	0.000258	CcSEcCtD
Ofloxacin—Headache—Stavudine—acquired immunodeficiency syndrome	6.5e-05	0.000257	CcSEcCtD
Ofloxacin—Vomiting—Abacavir—acquired immunodeficiency syndrome	6.5e-05	0.000257	CcSEcCtD
Ofloxacin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	6.49e-05	0.000256	CcSEcCtD
Ofloxacin—Pain—Delavirdine—acquired immunodeficiency syndrome	6.48e-05	0.000256	CcSEcCtD
Ofloxacin—Constipation—Delavirdine—acquired immunodeficiency syndrome	6.48e-05	0.000256	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	6.48e-05	0.000256	CcSEcCtD
Ofloxacin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	6.47e-05	0.000256	CcSEcCtD
Ofloxacin—Rash—Abacavir—acquired immunodeficiency syndrome	6.44e-05	0.000255	CcSEcCtD
Ofloxacin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	6.44e-05	0.000254	CcSEcCtD
Ofloxacin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	6.44e-05	0.000254	CcSEcCtD
Ofloxacin—Oedema—Lamivudine—acquired immunodeficiency syndrome	6.44e-05	0.000254	CcSEcCtD
Ofloxacin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	6.43e-05	0.000254	CcSEcCtD
Ofloxacin—Headache—Abacavir—acquired immunodeficiency syndrome	6.4e-05	0.000253	CcSEcCtD
Ofloxacin—Infection—Lamivudine—acquired immunodeficiency syndrome	6.4e-05	0.000253	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	6.39e-05	0.000252	CcSEcCtD
Ofloxacin—Nausea—Nevirapine—acquired immunodeficiency syndrome	6.38e-05	0.000252	CcSEcCtD
Ofloxacin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	6.38e-05	0.000252	CcSEcCtD
Ofloxacin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	6.34e-05	0.00025	CcSEcCtD
Ofloxacin—Shock—Lamivudine—acquired immunodeficiency syndrome	6.33e-05	0.00025	CcSEcCtD
Ofloxacin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	6.31e-05	0.000249	CcSEcCtD
Ofloxacin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	6.31e-05	0.000249	CcSEcCtD
Ofloxacin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	6.3e-05	0.000249	CcSEcCtD
Ofloxacin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	6.3e-05	0.000249	CcSEcCtD
Ofloxacin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	6.29e-05	0.000249	CcSEcCtD
Ofloxacin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	6.26e-05	0.000247	CcSEcCtD
Ofloxacin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	6.26e-05	0.000247	CcSEcCtD
Ofloxacin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	6.25e-05	0.000247	CcSEcCtD
Ofloxacin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	6.25e-05	0.000247	CcSEcCtD
Ofloxacin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	6.25e-05	0.000247	CcSEcCtD
Ofloxacin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	6.23e-05	0.000246	CcSEcCtD
Ofloxacin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	6.22e-05	0.000246	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.2e-05	0.000245	CcSEcCtD
Ofloxacin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.18e-05	0.000244	CcSEcCtD
Ofloxacin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6.18e-05	0.000244	CcSEcCtD
Ofloxacin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	6.17e-05	0.000244	CcSEcCtD
Ofloxacin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	6.17e-05	0.000244	CcSEcCtD
Ofloxacin—Nausea—Stavudine—acquired immunodeficiency syndrome	6.16e-05	0.000243	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	6.15e-05	0.000243	CcSEcCtD
Ofloxacin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	6.14e-05	0.000242	CcSEcCtD
Ofloxacin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	6.1e-05	0.000241	CcSEcCtD
Ofloxacin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	6.09e-05	0.000241	CcSEcCtD
Ofloxacin—Nausea—Abacavir—acquired immunodeficiency syndrome	6.07e-05	0.00024	CcSEcCtD
Ofloxacin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	6.06e-05	0.000239	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	6.05e-05	0.000239	CcSEcCtD
Ofloxacin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.04e-05	0.000239	CcSEcCtD
Ofloxacin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	6.02e-05	0.000238	CcSEcCtD
Ofloxacin—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.02e-05	0.000238	CcSEcCtD
Ofloxacin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	6.02e-05	0.000238	CcSEcCtD
Ofloxacin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	6.02e-05	0.000238	CcSEcCtD
Ofloxacin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	6e-05	0.000237	CcSEcCtD
Ofloxacin—Constipation—Ritonavir—acquired immunodeficiency syndrome	6e-05	0.000237	CcSEcCtD
Ofloxacin—Pain—Ritonavir—acquired immunodeficiency syndrome	6e-05	0.000237	CcSEcCtD
Ofloxacin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	5.99e-05	0.000237	CcSEcCtD
Ofloxacin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	5.99e-05	0.000237	CcSEcCtD
Ofloxacin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	5.96e-05	0.000236	CcSEcCtD
Ofloxacin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	5.94e-05	0.000235	CcSEcCtD
Ofloxacin—Pruritus—Indinavir—acquired immunodeficiency syndrome	5.93e-05	0.000234	CcSEcCtD
Ofloxacin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	5.87e-05	0.000232	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	5.86e-05	0.000232	CcSEcCtD
Ofloxacin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	5.84e-05	0.000231	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	5.83e-05	0.00023	CcSEcCtD
Ofloxacin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	5.82e-05	0.00023	CcSEcCtD
Ofloxacin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	5.82e-05	0.00023	CcSEcCtD
Ofloxacin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	5.78e-05	0.000228	CcSEcCtD
Ofloxacin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	5.78e-05	0.000228	CcSEcCtD
Ofloxacin—Constipation—Saquinavir—acquired immunodeficiency syndrome	5.77e-05	0.000228	CcSEcCtD
Ofloxacin—Pain—Saquinavir—acquired immunodeficiency syndrome	5.77e-05	0.000228	CcSEcCtD
Ofloxacin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	5.74e-05	0.000227	CcSEcCtD
Ofloxacin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	5.74e-05	0.000227	CcSEcCtD
Ofloxacin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	5.73e-05	0.000226	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	5.73e-05	0.000226	CcSEcCtD
Ofloxacin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	5.72e-05	0.000226	CcSEcCtD
Ofloxacin—Rash—Zidovudine—acquired immunodeficiency syndrome	5.69e-05	0.000225	CcSEcCtD
Ofloxacin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	5.68e-05	0.000225	CcSEcCtD
Ofloxacin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	5.68e-05	0.000224	CcSEcCtD
Ofloxacin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	5.67e-05	0.000224	CcSEcCtD
Ofloxacin—Headache—Zidovudine—acquired immunodeficiency syndrome	5.65e-05	0.000223	CcSEcCtD
Ofloxacin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	5.61e-05	0.000221	CcSEcCtD
Ofloxacin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	5.6e-05	0.000221	CcSEcCtD
Ofloxacin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	5.59e-05	0.000221	CcSEcCtD
Ofloxacin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	5.57e-05	0.00022	CcSEcCtD
Ofloxacin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	5.56e-05	0.00022	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	5.56e-05	0.00022	CcSEcCtD
Ofloxacin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	5.55e-05	0.000219	CcSEcCtD
Ofloxacin—Dizziness—Indinavir—acquired immunodeficiency syndrome	5.55e-05	0.000219	CcSEcCtD
Ofloxacin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	5.54e-05	0.000219	CcSEcCtD
Ofloxacin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	5.54e-05	0.000219	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.52e-05	0.000218	CcSEcCtD
Ofloxacin—Constipation—Lamivudine—acquired immunodeficiency syndrome	5.5e-05	0.000217	CcSEcCtD
Ofloxacin—Pain—Lamivudine—acquired immunodeficiency syndrome	5.5e-05	0.000217	CcSEcCtD
Ofloxacin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.44e-05	0.000215	CcSEcCtD
Ofloxacin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.42e-05	0.000214	CcSEcCtD
Ofloxacin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.36e-05	0.000212	CcSEcCtD
Ofloxacin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.36e-05	0.000212	CcSEcCtD
Ofloxacin—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.36e-05	0.000212	CcSEcCtD
Ofloxacin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.33e-05	0.000211	CcSEcCtD
Ofloxacin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.33e-05	0.000211	CcSEcCtD
Ofloxacin—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.33e-05	0.000211	CcSEcCtD
Ofloxacin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	5.3e-05	0.00021	CcSEcCtD
Ofloxacin—Rash—Indinavir—acquired immunodeficiency syndrome	5.29e-05	0.000209	CcSEcCtD
Ofloxacin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.28e-05	0.000209	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.26e-05	0.000208	CcSEcCtD
Ofloxacin—Headache—Indinavir—acquired immunodeficiency syndrome	5.25e-05	0.000208	CcSEcCtD
Ofloxacin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	5.24e-05	0.000207	CcSEcCtD
Ofloxacin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.19e-05	0.000205	CcSEcCtD
Ofloxacin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.17e-05	0.000204	CcSEcCtD
Ofloxacin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.11e-05	0.000202	CcSEcCtD
Ofloxacin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.09e-05	0.000201	CcSEcCtD
Ofloxacin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	5.09e-05	0.000201	CcSEcCtD
Ofloxacin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.04e-05	0.000199	CcSEcCtD
Ofloxacin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.03e-05	0.000199	CcSEcCtD
Ofloxacin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.01e-05	0.000198	CcSEcCtD
Ofloxacin—Rash—Efavirenz—acquired immunodeficiency syndrome	5e-05	0.000197	CcSEcCtD
Ofloxacin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	4.99e-05	0.000197	CcSEcCtD
Ofloxacin—Nausea—Indinavir—acquired immunodeficiency syndrome	4.98e-05	0.000197	CcSEcCtD
Ofloxacin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	4.97e-05	0.000196	CcSEcCtD
Ofloxacin—Headache—Efavirenz—acquired immunodeficiency syndrome	4.96e-05	0.000196	CcSEcCtD
Ofloxacin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	4.96e-05	0.000196	CcSEcCtD
Ofloxacin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.84e-05	0.000191	CcSEcCtD
Ofloxacin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.82e-05	0.00019	CcSEcCtD
Ofloxacin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.8e-05	0.000189	CcSEcCtD
Ofloxacin—Rash—Delavirdine—acquired immunodeficiency syndrome	4.78e-05	0.000189	CcSEcCtD
Ofloxacin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	4.78e-05	0.000189	CcSEcCtD
Ofloxacin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	4.77e-05	0.000189	CcSEcCtD
Ofloxacin—Headache—Delavirdine—acquired immunodeficiency syndrome	4.75e-05	0.000188	CcSEcCtD
Ofloxacin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.74e-05	0.000187	CcSEcCtD
Ofloxacin—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.71e-05	0.000186	CcSEcCtD
Ofloxacin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	4.64e-05	0.000183	CcSEcCtD
Ofloxacin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.62e-05	0.000182	CcSEcCtD
Ofloxacin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.62e-05	0.000182	CcSEcCtD
Ofloxacin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.55e-05	0.00018	CcSEcCtD
Ofloxacin—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.5e-05	0.000178	CcSEcCtD
Ofloxacin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.46e-05	0.000176	CcSEcCtD
Ofloxacin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.46e-05	0.000176	CcSEcCtD
Ofloxacin—Rash—Ritonavir—acquired immunodeficiency syndrome	4.42e-05	0.000175	CcSEcCtD
Ofloxacin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.42e-05	0.000174	CcSEcCtD
Ofloxacin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.4e-05	0.000174	CcSEcCtD
Ofloxacin—Headache—Ritonavir—acquired immunodeficiency syndrome	4.39e-05	0.000173	CcSEcCtD
Ofloxacin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.29e-05	0.000169	CcSEcCtD
Ofloxacin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.26e-05	0.000168	CcSEcCtD
Ofloxacin—Rash—Saquinavir—acquired immunodeficiency syndrome	4.25e-05	0.000168	CcSEcCtD
Ofloxacin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.25e-05	0.000168	CcSEcCtD
Ofloxacin—Headache—Saquinavir—acquired immunodeficiency syndrome	4.23e-05	0.000167	CcSEcCtD
Ofloxacin—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.16e-05	0.000164	CcSEcCtD
Ofloxacin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.09e-05	0.000162	CcSEcCtD
Ofloxacin—Rash—Lamivudine—acquired immunodeficiency syndrome	4.06e-05	0.00016	CcSEcCtD
Ofloxacin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.05e-05	0.00016	CcSEcCtD
Ofloxacin—Headache—Lamivudine—acquired immunodeficiency syndrome	4.03e-05	0.000159	CcSEcCtD
Ofloxacin—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.01e-05	0.000158	CcSEcCtD
Ofloxacin—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.82e-05	0.000151	CcSEcCtD
